Photo of Steve Kraus, Partner

Steve Kraus

Partner

Steve Kraus is a partner at Bessemer in the Cambridge office and a world-renowned healthcare investor. He is the author of Bessemer’s 10 Laws of Healthcare,  Benchmarks for Growing Health tech Businesses, and is a co-host of A Healthy Dose podcast. Steve currently sits on the boards of Bright Health Group, Headspace Health, Groups, Qventus, AspenRx, HouseRx, Oshi Health, Folx Health, Mural Health, and Alcresta.

Prior to joining Bessemer, Steve worked for a growth-stage, private equity firm and as a management consultant at Bain & Company. He has also worked on several different political campaigns throughout his career.

He serves as an Observer at Beth Israel Deaconess Medical Center, an advisor to Boston Children’s Hospital and the Harvard Business School’s Center for Entrepreneurship, and on the investment committees of BCBS Massachusetts and Rock Health.

Steve graduated from summa cum laude from Yale University and earned his MBA from Harvard, where he was a Baker Scholar.

“Innovating in healthcare is really hard and really rewarding. Make sure you work with people who understand the industry deeply and work in it for all the right reasons.”

Companies

Abridge

Abridge

Abridge records the details of your care and helps you stay on top of your health, one conversation at a time.

Acceleron *

Acceleron

NASDAQ: XLRN

Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics. Acceleron went public in September 2013 (NASDAQ: XLRN).

Allena Pharmaceuticals *

Allena Pharmaceuticals

NASDAQ: ALNA

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases. Allena Pharmaceuticals went public in November 2017 (NASDAQ: ALNA).

Artemis Health *

Artemis Health

ACQUIRED BY: NOMI HEALTH

Artemis Health's next-generation data optimization platform enables benefits teams to quantify the impact of their programs, justify new and better programs for their members, and drive their benefits strategy.

Artemis Health was acquired by Nomi Health in January 2022.

Aspen RxHealth

Aspen RxHealth

Aspen RxHealth is the leader in next-generation clinical pharmacy services, intelligently matching pharmacists with patients.

ClearCare

ClearCare

ClearCare is a cloud-based home care software provider. In 2017, ClearCare was acquired.

Clearing

Clearing

Clearing is a digital healthcare platform built to serve the more than 50M chronic pain sufferers in the United States.

DocuTAP *

DocuTAP

ACQUIRED BY: WARBURG PINCUS

DocuTAP provides urgent care EMR and practice management software for healthcare providers. DocuTAP was acquired by Warburg Pincus in 2016.

Flex Pharma, Inc. *

Flex Pharma, Inc.

NASDAQ: FLKS

Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms. In January 2015, Flex Pharma went public (NASDAQ: FLKS).

Folx Health

Folx Health

Folx Health is a digital health provider designed with the medical needs and goals of the LGBTQIA+ community in mind.

Ginger *

Ginger

MERGED WITH: HEADSPACE

Ginger is an on-demand mental health company that brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone.

Ginger announced they will merge with Headspace in August 2021.

Groups

Groups

Groups helps people recover from opiate use through therapy and medication.

Hinge Health

Hinge Health

Hinge Health pioneers the world's most patient-centered digital hospital, starting with musculoskeletal health.

Insmed *

Insmed

NASDAQ: INSM

Insmed is a biopharmaceutical company dedicated to improving the lives of patients battling serious lung diseases. In 2000, Insmed went public (NASDAQ: INSM).

Kymera Therapeutics *

Kymera Therapeutics

(NASDAQ: KYMR)

Kymera Therapeutics is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases.

Kymera went public in August 2020 (NASDAQ: KYMR).

Liazon *

Liazon

ACQUIRED BY: TOWERS WATSON & CO.

Liazon is an online benefits store that operates private benefits exchange for businesses. In November 2013, Liazon was acquired by Towers Watson & Co.

Lumere *

Lumere

ACQUIRED BY: GLOBAL HEALTH EXCHANGE

Lumere (formerly Procured Health) is a software company which provides insights to health care variation and cost reduction. Lumere was acquired by Global Healthcare Exchange in 2020.

Nido Biosciences

Nido Biosciences

Nido Biosciences is the developer of small molecule therapeutics designed to treat neurodegenerative diseases.

Nym

Nym

Nym is a NLU based autonomous medical coding technology that enables healthcare facilities to optimize their revenue cycle processes.

OvaScience *

OvaScience

NASDAQ: OVSC

OvaScience is a biotechnology company focused on female infertility. OvaScience (NASDAQ: OVAS) became a public company in 2012.

Qventus

Qventus

Qventus optimizes decisions in hospitals in real time to reduce costs, improve quality and experience.

Stromedix *

Stromedix

ACQUIRED BY: BIOGEN IDEC.

Stromedix is a biomedical company focused on drugs for fibrosis, organ failure and cancer. In 2012, Stromedix was acquired by Biogen Idec.

Subtle Medical

Subtle Medical

Subtle Medical uses AI to redefine the standards for medical imaging, making it faster, safer, and smarter.

TScan Therapeutics *

TScan Therapeutics

NASDAQ: TCRX

TScan Therapeutics is harnessing novel T cell systems to extend the promise of immunotherapy.

TScan went public in July 2021 (NASDAQ: TCRX).

Verastem *

Verastem

NASDAQ: VSTM

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. In January 2012, Verastem went public (NASDAQ: VSTM).

Verata Health *

Verata Health

ACQUIRED BY: OLIVE

Verata Health is the developer of an artificial intelligence platform intented to improve the prior authorization process for private practices, hospitals, and health systems. Verata Health was acquired by Olive in December 2020.

Welltok

Welltok

Welltok is a enterprise SaaS company that delivers the healthcare industry’s consumer activation platform.

Welltok was acquired by Virgin Pulse in November 2021.

Insights from Atlas

In the News